For-profit acute and behavioral hospital operator Universal Health Services is acquiring virtual behavioral care provider Talkspace, the companies announced on Monday.
The definitive agreement would see Talkspace acquired for $5.25 per share. That translates to an enterprise value of about $835 million, according to the announcement. The deal is expected to close in Q3. UHS will finance the purchase with debt in line with its existing revolving credit facility.
The end goal, the companies said, is to create a national, end-to-end platform for behavioral health while expanding access to commercially-insured patient populations.
“This acquisition aligns with UHS’ core growth objectives by accelerating our outpatient and telehealth behavioral health strategies, diversifying our payor mix and delivering a comprehensive, technology-enabled continuum of care,” Marc D. Miller, president and CEO of UHS, said in an announcement.
UHS executives, in recent earnings calls, have highlighted efforts at the company to improve the throughput of behavioral patients and address behavioral clinician workforce shortages that put a cap on volumes. To date, that has comprised an increased focus on “step-down” care that continues at lower acuity settings after a patient has been discharged from the hospital.
In Monday’s announcement, UHS noted that the virtual care company’s offering “facilitates seamless transitions across care settings and improves access for payors and consumers alike.”
UHS Chief Financial Officer Steve Filton underscored those points in a Monday morning fireside chat at the Leerink Global Healthcare Conference, describing the deal as an “accelerant” to UHS’ outpatient push.
“For the last year or two, we have really been focused on, in our behavioral segment especially, building our presence in the outpatient space, and have done a number of internal things to accelerate that,” he said. “By acquiring Talkspace, we’re acquiring their cadre of 6,000 therapists, many of whom Talkspace believes have additional capacity as more demand is created—and we believe this acquisition will create more demand.”
Filton went on to describe virtual care capabilities as particularly appealing to patients who may not want to travel to UHS’ campuses, as well as to younger populations that are “really drawn to virtual care.” The flow of patients should also be “bi-directional” as Talkspace refers members who need more intensive outpatient, partial hospitalization or inpatient care to UHS facilities, he added.
Publicly traded UHS saw shrinking volumes in 2025, though had a positive growth outlook for 2026. In the fourth quarter of 2025, UHS reported a 9.1% year-over-year net revenue increase to $4.5 billion and $5.88 adjusted earnings per diluted share ($371.4 million adjusted net income attributed to UHS, $445.9 million as-reported net income attributed to UHS).
Also in the last quarter of 2025, within the UHS behavioral health business, net revenues increased 8.6% to above $1.9 billion for the quarter and by 7.2% to more than $1.8 billion on a same-store basis. The health system plans to open two de novo behavioral health projects totaling 264 beds this year, as well as 10 new outpatient branches.
Talkspace connects people via an app with therapists who provide counseling remotely, either over the phone, by video chat or by text. The company’s suite of mental health services includes therapy for individuals, teens and couples as well as psychiatric treatment and medication management. Its services are available to over 200 million members through commercial payers, Medicare, Medicare Advantage and TRICARE. Individuals also have access to Talkspace’s services through employee assistance programs (EAPs), its partnerships with leading healthcare companies or as a free benefit through their employer, school or government agency.
In 2025, Talkspace saw strong results with $229 million in revenue, driven in part by YoY increases in pay revenue, and a net income of $4.8 million. While Talkspace’s growth is propelled by its expanding payer business, the company is also exploring opportunities in the pharma space to support patients. The company is working with Novo Nordisk to support patients taking weight-loss drugs.
“Over the past several years, Talkspace has transformed from a direct-to-consumer pioneer into a scaled, insurance-covered behavioral healthcare platform trusted by patients, providers, payors and employers,” Jon R. Cohen, M.D., CEO of Talkspace, said in an announcement. “This transaction reflects the next logical step in expanding access to affordable, high- quality mental healthcare by integrating outpatient virtual care into a modern behavioral health ecosystem.”
Talkspace has focused on using artificial intelligence to cut down the administrative burden on providers and improve the patient experience. Use cases include AI assistance to improve eligibility determination for insurance and smart insights for providers to prepare their sessions. Members are more likely to book follow-up sessions when providers use these insights, the company has found.
Talkspace also has risk algorithms to flag suicide risk and is building out a behavioral health AI model trained on its internal, de-identified clinical data. The goal is to build a therapy companion and clinical support tool, based on anonymized therapy transcripts and rigorously tested for safety and therapeutic quality, Cohen has previously said.
Filton said that following the deal, Talkspace’s infrastructure and technology will “for the most part … remain in place,” as will its leadership team.
UHS said it expects the deal to be slightly accretive to its adjusted net income during the first year after close (excluding purchase costs), and increasingly accretive as time goes on.
Filton described the transaction as primarily driven by the opportunity for additional revenues, as opposed to other deals focused on cost savings. Though financing the purchase will bump UHS’ debt leverage up 0.3x (bringing the company to about 2.1x leverage, on the low end of its stated target range), he stressed that UHS will remain “an opportunistic deployer of capital, meaning if other M&A opportunities arise, we’ll evaluate them and respond if appropriate.”